United Laboratories International Holdings (FRA:UNJ) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:UNJ United Laboratories International Holdings Ltd FRA:UNJ
85 GF Score
Price €1.00
GF Value €0.96
! 5 Warning Signs
View Full Analysis

What is United Laboratories International Holdings Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

FRA:UNJ
85GF Score
United Laboratories International Holdings Ltd FRA:UNJ
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is United Laboratories International Holdings (FRA:UNJ) Overvalued in 2026?

Based on GuruFocus' analysis, United Laboratories International Holdings stock appears to be overvalued. The current stock price of €1.00 is trading 4.2% above its estimated GF Value™ of €0.96.

Key valuation signals for FRA:UNJ:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €0.96 vs. price of €1.00 (4.2% above fair value)
  • GF Score™: 85/100 with 5 warning signs

No single metric tells the full story. See the FRA:UNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


United Laboratories International Holdings Business Description

Address No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is mainly engaged in the research and development, production and sales of pharmaceuticals. The company operates in three segments: Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Finished products segment, followed by Bulk medicine. The majority of the company's sales are generated in China, followed by Europe, India and other countries.
85GF Score

Get the complete analysis for FRA:UNJ

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.00
Price
€0.96
GF Value